Biotechnology News

MENLO PARK, Calif., April 02, 2019 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN) today announced that John A. Scarlett, M.D., Chairman and Chief Executive Officer, is scheduled to present a...

CAMBRIDGE, Mass., April 02, 2019 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (NASDAQ: VYGR), a clinical-stage gene therapy company focused on developing life-changing treatments for severe...

ALPHARETTA, Ga., April 02, 2019 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing treatments that restore and preserve vision for...

Rensselaer, NY, April 02, 2019 (GLOBE NEWSWIRE) -- A Taconic Biosciences, líder global no fornecimento de soluções de modelos de roedores geneticamente modificados, anuncia que obteve uma licença...

RENSSELAER, New York, USA, April 02, 2019 (GLOBE NEWSWIRE) -- Taconic Biosciences, ein weltweit führender Anbieter von gentechnisch veränderten, auf Nagetiermodellen basierenden Lösungen, gibt...

RENSSELAER, New York, 02 avr. 2019 (GLOBE NEWSWIRE) -- Taconic Biosciences, un chef de file mondial dans la fourniture de modèles de rongeurs génétiquement modifiés, annonce qu'elle a reçu une...

RENSSELAER, N.Y., April 03, 2019 (GLOBE NEWSWIRE) -- Taconic Biosciences, peneraju global dalam membekalkan penyelesaian model roden kejuruteraan genetik, mengumumkan bahawa ia telah memperoleh...

미국 뉴욕주 렌셀러, April 03, 2019 (GLOBE NEWSWIRE) -- 유전자 변형 설치류 모델 솔루션 공급사인 타코닉 바이오사이언스(Taconic Biosciences)는 미국국립보건원(NIH) 산하 국립 당뇨·소화·신장질환연구소(NIDDK)로부터 장내 마이크로바이옴 Wild Mouse에 대한 라이선스를 취득했다고 밝혔다. 야생 마우스...

日ニューヨーク州レンセリア発, April 03, 2019 (GLOBE NEWSWIRE) -- 遺伝子組み換え操作を行った齧歯類モデルソリューション提供におけるグローバルリーダーであるタコニック･バイオサイエンシズ (Taconic Biosciences) は、国立衛生研究所 (National Institutes of Health: NIH)...

紐約州壬色列縣, April 03, 2019 (GLOBE NEWSWIRE) -- 轉基因囓齒動物模型解決方案的全球領導者 Taconic Biosciences 宣佈，已獲美國國家衛生局 (NIH) 旗下的美國糖尿病、消化及腎病研究中心 (NIDDK) 授予野生小鼠腸道微生物組許可。 ...